AAP: Nasal Spray Influenza Vaccine Acceptable for 2019-2020 Season
The AAP says that in the 2019 to 2020 flu season, it will support the use of any licensed influenza vaccine, in accordance with guidance from the CDC.
Influenza
CDC: Flu Season May Have Peaked
Though there has been a recent rise in the number of cases involving a more severe flu strain, flu season in the US has peaked.
The CDC Estimates 2018-2019 Seasonal Influenza Vaccine Effectiveness
Influenza vaccine efficacy, between November 23, 2018 and February 2, 2019, was 47% overall and 61% for young children.
Flu Vaccination During Pregnancy Does Not Cause Miscarriage
Not only is an influenza vaccine during pregnancy safe, it is necessary.
Antiviral Agents Compared for Treatment of Influenza
In otherwise healthy patients, influenza treatment with baloxavir marboxil was found to be comparable, and on some efficacy measures, superior to neuraminidase inhibitors.
2017-2018 Influenza Vaccine Prevents Substantial Burden
The current available influenza vaccine may have prevented substantial cases of influenza-associated adverse outcomes.
CDC: Severity of Influenza Season Low Through February 2, 2019
The 2018 to 2019 influenza season has been low in severity so far, and overall vaccine effectiveness is about 47%.
Effectiveness of Live Attenuated vs Inactivated Influenza Vaccine in Children
In pediatric patients aged 2-17 years, the live attenuated vaccine was less effective against influenza A/H1N1pdm09 compared with the inactivated vaccine.
New Dosing Option for Fluzone Quadrivalent in Children as Young as 6 Months
The Food and Drug Administration (FDA) has approved the expanded use of Fluzone Quadrivalent(influenza vaccine; Sanofi Pasteur) 0.5mL to include pediatric patients aged 6 through 35 months. Both the 0.25mL and 0.5mL will be available for the upcoming 2019/20 flu season for this age range. The approval was based on findings from a Phase 4…
World Health Organization: Five-Year Plan to Address 10 Biggest Global Health Threats
In an effort to effectively address global health concerns, the WHO has announced the 13th General Programme of Work, a 5-year strategic plan spanning from 2019 to 2023.
Next post in Medicine
